Vaccine and Booster Information

05-23-22 AND 05-26-22

Center for Disease Control (CDC) Updates

Date of Record:  May 20, 2022


CDC has updated its guidance for COVID-19 vaccination, including:


  • New guidance for use of a Pfizer-BioNTech COVID-19 Vaccine booster dose in children ages 5–11 years

  • Updated guidance that the following people should receive a second COVID-19 booster dose
    • People ages 12 years and older who are moderately or severely immunocompromised
    • People ages 50 years and older
  • Updated guidance for people who are moderately or severely immunocompromised and are treated with B-cell-depleting therapies

  • Updated guidance for primary series vaccination after SARS-CoV-2 infection

  • Clarification of COVID-19 vaccination guidance for multisystem inflammatory syndrome in children (MIS-C) and adults (MIS-A)


To view all updates, please visit CDC’s Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States.